Sunday, March 2, 2008

News to Know: Lilly CEO, Predicting Future of Sales Reps

Lily CEO, Sidney Taurel, who is currently stepping down has another prediction for the future of the sales reps that some are claiming to be outlandish to say the least. He claims sales reps, in the future, will be paid and evaluated based on the health of the patients in their sales territories. For instance, "reps pitching diabetes drugs [...] might be measured in part on improvements in patients' blood sugar." (Jacob Goldstien, WSJ)

To read the posting on Wall Street Journal's Health BLOG: Click Here

Tell us what you think!

Comment Below

1 comment:

Manger La Ville said...

What if a CEO were paid by the positive impact he/she made in the community?
I think if Mr. Taurel wants to hold sales reps to these standards, why not hold everyone, doctors, CEOs etc...